All three PHD isoforms were strongly expressed in normal lungs, whereas 24 (32.9%), 33 (45.2%), and 36 (49.3%) NSCLC samples had high expression of PHD1, PHD2, and PHD3, respectively. The gene discussed is EGLN1; the disease is non-small cell lung carcinoma.